Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17. (Q48064172)
Jump to navigation
Jump to search
scientific article published on 30 September 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17. |
scientific article published on 30 September 2014 |
Statements
1 reference
Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17. (English)
1 reference
S Lightman
H Longhurst
W Lynn
R Moots
M Stanford
D Yang
V L Calder
30 September 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference